Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Next Generation Cancer Diagnostics market report explains the definition, types, applications, major countries, and major players of the Next Generation Cancer Diagnostics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Janssen Global Services
Genomic Health
Novartis AG
Cepheid
Koninklijke Philips NV
Hologic
Almac Group
Agilent Technologies
PerkinElmer
Illumina
Thermo Fisher Scientific
GE Healthcare
F Hoffmann-La Roche Ltd
Sysmex Corporation
Abbott
Qiagen
Opko Health
Myriad Genetics
By Type:
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
By End-User:
Hospitals
Clinics
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Next Generation Cancer Diagnostics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Next Generation Cancer Diagnostics Outlook to 2028- Original Forecasts
-
2.2 Next Generation Cancer Diagnostics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Next Generation Cancer Diagnostics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Next Generation Cancer Diagnostics Market- Recent Developments
-
6.1 Next Generation Cancer Diagnostics Market News and Developments
-
6.2 Next Generation Cancer Diagnostics Market Deals Landscape
7 Next Generation Cancer Diagnostics Raw Materials and Cost Structure Analysis
-
7.1 Next Generation Cancer Diagnostics Key Raw Materials
-
7.2 Next Generation Cancer Diagnostics Price Trend of Key Raw Materials
-
7.3 Next Generation Cancer Diagnostics Key Suppliers of Raw Materials
-
7.4 Next Generation Cancer Diagnostics Market Concentration Rate of Raw Materials
-
7.5 Next Generation Cancer Diagnostics Cost Structure Analysis
-
7.5.1 Next Generation Cancer Diagnostics Raw Materials Analysis
-
7.5.2 Next Generation Cancer Diagnostics Labor Cost Analysis
-
7.5.3 Next Generation Cancer Diagnostics Manufacturing Expenses Analysis
8 Global Next Generation Cancer Diagnostics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Next Generation Cancer Diagnostics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Next Generation Cancer Diagnostics Export by Region (Top 10 Countries) (2017-2028)
9 Global Next Generation Cancer Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Next Generation Cancer Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Next Generation Sequencing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global qPCR & Multiplexing Consumption and Growth Rate (2017-2022)
-
9.1.3 Global DNA Microarrays Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Next Generation Cancer Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Next Generation Cancer Diagnostics Market Analysis and Outlook till 2022
-
10.1 Global Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.2.2 Canada Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.2.3 Mexico Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.2 UK Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.3 Spain Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.4 Belgium Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.5 France Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.6 Italy Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.7 Denmark Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.8 Finland Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.9 Norway Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.10 Sweden Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.11 Poland Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.12 Russia Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.3.13 Turkey Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.2 Japan Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.3 India Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.4 South Korea Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.5 Pakistan Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.6 Bangladesh Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.7 Indonesia Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.8 Thailand Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.9 Singapore Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.10 Malaysia Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.11 Philippines Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.4.12 Vietnam Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.5.2 Colombia Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.5.3 Chile Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.5.4 Argentina Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.5.5 Venezuela Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.5.6 Peru Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.5.7 Puerto Rico Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.5.8 Ecuador Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.6.2 Kuwait Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.6.3 Oman Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.6.4 Qatar Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.7.2 South Africa Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.7.3 Egypt Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.7.4 Algeria Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Next Generation Cancer Diagnostics Consumption (2017-2022)
-
10.8.2 New Zealand Next Generation Cancer Diagnostics Consumption (2017-2022)
11 Global Next Generation Cancer Diagnostics Competitive Analysis
-
11.1 Janssen Global Services
-
11.1.1 Janssen Global Services Company Details
-
11.1.2 Janssen Global Services Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Janssen Global Services Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.1.4 Janssen Global Services Next Generation Cancer Diagnostics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Genomic Health
-
11.2.1 Genomic Health Company Details
-
11.2.2 Genomic Health Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Genomic Health Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.2.4 Genomic Health Next Generation Cancer Diagnostics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Novartis AG
-
11.3.1 Novartis AG Company Details
-
11.3.2 Novartis AG Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Novartis AG Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.3.4 Novartis AG Next Generation Cancer Diagnostics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Cepheid
-
11.4.1 Cepheid Company Details
-
11.4.2 Cepheid Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Cepheid Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.4.4 Cepheid Next Generation Cancer Diagnostics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Koninklijke Philips NV
-
11.5.1 Koninklijke Philips NV Company Details
-
11.5.2 Koninklijke Philips NV Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Koninklijke Philips NV Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.5.4 Koninklijke Philips NV Next Generation Cancer Diagnostics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Hologic
-
11.6.1 Hologic Company Details
-
11.6.2 Hologic Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Hologic Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.6.4 Hologic Next Generation Cancer Diagnostics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Almac Group
-
11.7.1 Almac Group Company Details
-
11.7.2 Almac Group Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Almac Group Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.7.4 Almac Group Next Generation Cancer Diagnostics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Agilent Technologies
-
11.8.1 Agilent Technologies Company Details
-
11.8.2 Agilent Technologies Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Agilent Technologies Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.8.4 Agilent Technologies Next Generation Cancer Diagnostics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 PerkinElmer
-
11.9.1 PerkinElmer Company Details
-
11.9.2 PerkinElmer Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 PerkinElmer Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.9.4 PerkinElmer Next Generation Cancer Diagnostics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Illumina
-
11.10.1 Illumina Company Details
-
11.10.2 Illumina Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Illumina Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.10.4 Illumina Next Generation Cancer Diagnostics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Thermo Fisher Scientific
-
11.11.1 Thermo Fisher Scientific Company Details
-
11.11.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.11.4 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 GE Healthcare
-
11.12.1 GE Healthcare Company Details
-
11.12.2 GE Healthcare Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 GE Healthcare Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.12.4 GE Healthcare Next Generation Cancer Diagnostics Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 F Hoffmann-La Roche Ltd
-
11.13.1 F Hoffmann-La Roche Ltd Company Details
-
11.13.2 F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.13.4 F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Sysmex Corporation
-
11.14.1 Sysmex Corporation Company Details
-
11.14.2 Sysmex Corporation Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Sysmex Corporation Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.14.4 Sysmex Corporation Next Generation Cancer Diagnostics Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Abbott
-
11.15.1 Abbott Company Details
-
11.15.2 Abbott Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Abbott Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.15.4 Abbott Next Generation Cancer Diagnostics Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Qiagen
-
11.16.1 Qiagen Company Details
-
11.16.2 Qiagen Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Qiagen Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.16.4 Qiagen Next Generation Cancer Diagnostics Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Opko Health
-
11.17.1 Opko Health Company Details
-
11.17.2 Opko Health Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Opko Health Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.17.4 Opko Health Next Generation Cancer Diagnostics Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Myriad Genetics
-
11.18.1 Myriad Genetics Company Details
-
11.18.2 Myriad Genetics Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Myriad Genetics Next Generation Cancer Diagnostics Main Business and Markets Served
-
11.18.4 Myriad Genetics Next Generation Cancer Diagnostics Product Portfolio
-
11.18.5 Recent Research and Development Strategies
12 Global Next Generation Cancer Diagnostics Market Outlook by Types and Applications to 2028
-
12.1 Global Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Next Generation Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global qPCR & Multiplexing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global DNA Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Next Generation Cancer Diagnostics Market Analysis and Outlook to 2028
-
13.1 Global Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.2.2 Canada Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.2 UK Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.3 Spain Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.5 France Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.6 Italy Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.8 Finland Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.9 Norway Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.11 Poland Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.12 Russia Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.2 Japan Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.3 India Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.5.3 Chile Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.5.6 Peru Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.6.3 Oman Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Next Generation Cancer Diagnostics
-
Figure of Next Generation Cancer Diagnostics Picture
-
Table Global Next Generation Cancer Diagnostics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Next Generation Cancer Diagnostics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Next Generation Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global qPCR & Multiplexing Consumption and Growth Rate (2017-2022)
-
Figure Global DNA Microarrays Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Next Generation Cancer Diagnostics Consumption by Country (2017-2022)
-
Table North America Next Generation Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure United States Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Canada Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Next Generation Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure Germany Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure UK Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Spain Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure France Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Italy Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Finland Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Norway Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Poland Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Russia Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table APAC Next Generation Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure China Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table South America Next Generation Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure Brazil Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Chile Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Peru Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table GCC Next Generation Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure Bahrain Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Oman Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Africa Next Generation Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure Nigeria Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Oceania Next Generation Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure Australia Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Janssen Global Services Company Details
-
Table Janssen Global Services Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Global Services Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Janssen Global Services Next Generation Cancer Diagnostics Product Portfolio
-
Table Genomic Health Company Details
-
Table Genomic Health Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genomic Health Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Genomic Health Next Generation Cancer Diagnostics Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Novartis AG Next Generation Cancer Diagnostics Product Portfolio
-
Table Cepheid Company Details
-
Table Cepheid Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cepheid Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Cepheid Next Generation Cancer Diagnostics Product Portfolio
-
Table Koninklijke Philips NV Company Details
-
Table Koninklijke Philips NV Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Koninklijke Philips NV Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Koninklijke Philips NV Next Generation Cancer Diagnostics Product Portfolio
-
Table Hologic Company Details
-
Table Hologic Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hologic Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Hologic Next Generation Cancer Diagnostics Product Portfolio
-
Table Almac Group Company Details
-
Table Almac Group Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almac Group Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Almac Group Next Generation Cancer Diagnostics Product Portfolio
-
Table Agilent Technologies Company Details
-
Table Agilent Technologies Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Agilent Technologies Next Generation Cancer Diagnostics Product Portfolio
-
Table PerkinElmer Company Details
-
Table PerkinElmer Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table PerkinElmer Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table PerkinElmer Next Generation Cancer Diagnostics Product Portfolio
-
Table Illumina Company Details
-
Table Illumina Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Illumina Next Generation Cancer Diagnostics Product Portfolio
-
Table Thermo Fisher Scientific Company Details
-
Table Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table GE Healthcare Next Generation Cancer Diagnostics Product Portfolio
-
Table F Hoffmann-La Roche Ltd Company Details
-
Table F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Portfolio
-
Table Sysmex Corporation Company Details
-
Table Sysmex Corporation Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sysmex Corporation Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Sysmex Corporation Next Generation Cancer Diagnostics Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Abbott Next Generation Cancer Diagnostics Product Portfolio
-
Table Qiagen Company Details
-
Table Qiagen Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Qiagen Next Generation Cancer Diagnostics Product Portfolio
-
Table Opko Health Company Details
-
Table Opko Health Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Opko Health Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Opko Health Next Generation Cancer Diagnostics Product Portfolio
-
Table Myriad Genetics Company Details
-
Table Myriad Genetics Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myriad Genetics Next Generation Cancer Diagnostics Main Business and Markets Served
-
Table Myriad Genetics Next Generation Cancer Diagnostics Product Portfolio
-
Figure Global Next Generation Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global qPCR & Multiplexing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DNA Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Table North America Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Germany Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure China Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Australia Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
